Home » Topics » BioWorld Science

BioWorld Science
RSS

Liver protein improves brain function after exercise

July 10, 2020

Kitov initiates phase I/II study of NT-219 in advanced cancers

July 10, 2020

FDA clears IND Application for phase I study of FT-819

July 10, 2020

Pan-TRK/ROS1 dual inhibitor XZP-5955 shows brain penetration, activity against mutations

July 10, 2020

Sorrento Therapeutics presents preclinical data on STI-6129 for multiple myeloma

July 10, 2020

Phase III FIDELIO-DKD study of finerenone meets primary endpoint

July 10, 2020

Janssen Pharmaceutica and Johnson & Johnson present new HBV antivirals

July 10, 2020

Camphor Pharmaceuticals synthesizes CDK4 and/or CDK6 inhibitors

July 10, 2020

Shenzhen Targetrx Biotechnology divulges new protein kinase inhibitors

July 10, 2020

Chinese investigators identify new ER antagonists

July 10, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...